April 27, 2024
Market Now
Feelux’s subsidiary to acquire US bio firm at W16.1b
[DISCLOSURE] Feelux (033180) announced on June 12 that its subsidiary CAR-TCellKor has decided to take over 100 percent stake in US bio company Liminatus Pharma at 16.1 billion won (US$14.98 million).
This amounts to 8.39 percent of its equity capital.
By Hwang You-mee (glamazon@heraldcorp.com)
This amounts to 8.39 percent of its equity capital.
By Hwang You-mee (glamazon@heraldcorp.com)
